CAR-ENGINEERED PRIMARY NK CELLS SHOW PROMISING EFFECTS AS TARGETED THERAPY AGAINST EGFR-POSITIVE GLIOBLASTOMA

被引：0
|
作者：
Roller, B. [1 ,2 ]
Reindl, L. [2 ,3 ]
Strassheimer, F. [1 ,2 ]
Ziegener, L. [1 ,2 ]
Elleringmann, P. [1 ,2 ]
Kiefer, A. [4 ]
Roeder, J. [2 ,4 ]
Steinbach, J. [1 ,2 ]
Wels, W. [2 ,4 ]
Ullrich, E. [3 ]
Burger, M.
机构：
[1] Dr Senckenberg Inst Neurooncol, Frankfurt, Germany
[2] Goethe Univ Frankfurt, Frankfurt Canc Inst FCI, Frankfurt, Germany
[3] Goethe Univ, Childrens Hosp, Frankfurt, Germany
[4] Georg Speyer Haus, Inst Tumor Biol & Expt Therapy, Frankfurt, Germany
来源：
NEURO-ONCOLOGY | 2024年 / 26卷
关键词：
D O I：
10.1093/neuonc/noae144.217
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
P12.04.A
引用
收藏
页码：V66 / V66
页数：1
相关论文
共 50 条
  • [41] Cord Blood NK Cells Engineered to Express IL-15 and CD19-Targeted CAR Show Long-Term Persistence and Potent Anti-Tumor Activity
    Liu, Enli
    Tong, Yijiu
    Dotti, Gianpietro
    Savoldo, Barbara
    Mukherjee, Malini
    Orange, Jordan
    Shaim, Hila
    Lu, Xinyan
    Reynolds, Alexandra
    Gagea, Mihai
    Muftuoglu, Muharrem
    Li, Li
    Marin, David
    Wierda, William
    Keating, Michael
    Champlin, Richard
    Shpall, Elizabeth
    Rezvani, Katy
    MOLECULAR THERAPY, 2017, 25 (05) : 267 - 268
  • [42] Dual Targeting of Glioblastoma Cells with Bispecific Killer Cell Engagers Directed to EGFR and ErbB2 (HER2) Facilitates Effective Elimination by NKG2D-CAR-Engineered NK Cells
    Kiefer, Anne
    Pruefer, Maren
    Roeder, Jasmin
    Serrahima, Jordi Pfeifer
    Bodden, Malena
    Kuehnel, Ines
    Oberoi, Pranav
    Wels, Winfried S.
    CELLS, 2024, 13 (03)
  • [43] OFF-THE-SHELF, ENGINEERED IPSC-DERIVED NK CELLS MEDIATE POTENT CYTOTOXIC ACTIVITY AGAINST PRIMARY GLIOBLASTOMA CELLS AND PROMOTE DURABLE LONG-TERM SURVIVAL IN VIVO
    Cichocki, Frank
    Ning, Jianfang
    Davis, Zachary
    Wang, Hongbo
    Tuininga, Katie
    Bjordahl, Ryan
    Rogers, Paul
    Ge, Moyar
    Lee, Tom
    Valamehr, Bob
    Chen, Clark
    Miller, Jeffrey
    JOURNAL FOR IMMUNOTHERAPY OF CANCER, 2021, 9 : A180 - A180
  • [44] COMBINATION THERAPY OF CAR-NK CELLS AND ANTI-PD-1 ANTIBODY DISPLAYS POTENT EFFICACY AGAINST LATE-STAGE GLIOBLASTOMA AND INDUCES PROTECTIVE ANTITUMOR IMMUNITY
    Strassheimer, F.
    Zhang, C.
    Mildenberger, I. C.
    Harter, P. N.
    Tonn, T.
    Steinbach, J. P.
    Wels, W. S.
    Burger, M. C.
    NEURO-ONCOLOGY, 2018, 20 : 283 - 283
  • [45] Cord Blood NK Cells Engineered to Express a Humanized CD123-Targeted Chimeric Antigen Receptor (CAR) and IL-15 As Off-the-Shelf Therapy for Acute Myeloid Leukemia
    Kerbauy, Lucila Nassif
    Ang, Sonny
    Liu, Enli
    Banerjee, Pinaki P.
    Wu, Yewen
    Shaim, Hila
    Lim, Francesca Lorraine Wei Inng
    Basar, Rafet
    Li, Li
    Muftuoglu, Muharrem
    Daher, May
    Imahashi, Nobuhiko
    Mendt, Mayela Carolina
    Kaplan, Mecit
    Mukherjee, Malini
    Lee, Jessica C. H.
    Orange, Jordan S.
    Konopleva, Marina
    Andreeff, Michael
    Champlin, Richard E.
    Shpall, Elizabeth J.
    Rezvani, Katayoun
    BLOOD, 2017, 130
  • [46] COMBINATION THERAPY OF CAR-NK-CELLS AND ANTI-PD-1 ANTIBODY RESULTS IN HIGH EFFICACY AGAINST ADVANCED-STAGE GLIOBLASTOMA IN A SYNGENEIC MOUSE MODEL AND INDUCES PROTECTIVE ANTITUMOR IMMUNITY IN VIVO
    Strassheimer, F.
    Strecker, M. I.
    Alekseeva, T.
    Macas, J.
    Demes, M. C.
    Mildenberger, I. C.
    Tonn, T.
    Wild, P. J.
    Sevenich, L.
    Reiss, Y.
    Harter, P. N.
    Plate, K. H.
    Wels, W. S.
    Steinbach, J. P.
    Burger, M. C.
    JOURNAL FOR IMMUNOTHERAPY OF CANCER, 2020, 8 : A46 - A47
  • [47] SYNERGISTIC EFFECTS OF COMBINATION THERAPY OF CAR-NK CELLS AND ANTI-PD-1 ANTIBODY RESULT IN HIGH EFFICACY AGAINST ADVANCED STAGE ORTHOTOPIC GLIOBLASTOMA GRAFTS IN A SYNGENEIC MOUSE MODEL AND INDUCE PROTECTIVE ANTI-TUMOR IMMUNITY IN VIVO
    Strassheimer, F.
    Strecker, M. I.
    Zhang, C.
    Mildenberger, I. C.
    Harter, P. N.
    Tonn, T.
    Steinbach, J. P.
    Wels, W. S.
    Burger, M. C.
    NEURO-ONCOLOGY, 2019, 21 : 60 - 60
  • [48] COMBINATION THERAPY OF CAR-NK-CELLS AND ANTI-PD-1 RESULTS IN HIGH EFFICACY AGAINST ADVANCED-STAGE GLIOBLASTOMA IN A SYNGENEIC MOUSE MODEL AND INDUCES PROTECTIVE ANTI-TUMOR IMMUNITY IN VIVO
    Strassheimer, F.
    Strecker, M. I.
    Alekseeva, T.
    Macas, J.
    Demes, M. C.
    Mildenberger, I. C.
    Tonn, T.
    Wild, P. J.
    Sevenich, L.
    Reiss, Y.
    Harter, P. N.
    Plate, K. H.
    Wels, W. S.
    Steinbach, J. P.
    Burger, M. C.
    NEURO-ONCOLOGY, 2021, 23 : 15 - 15
  • [49] Combination therapy of CAR-NK-cells and anti-PD-1 antibody results in high efficacy against advanced-stage glioblastoma in syngeneic mouse model and induces protective anti-tumor immunity in vivo
    Strassheimer, F.
    Strecker, M. I.
    Zhang, C.
    Mildenberger, I. C.
    Harter, P. N.
    Tonn, T.
    Steinbach, J. P.
    Wels, W. S.
    Burger, M. C.
    EUROPEAN JOURNAL OF IMMUNOLOGY, 2019, 49 : 1714 - 1715
  • [50] Combination therapy of CAR-NK-cells and anti-PD-1 antibody results in high efficacy against advanced-stage glioblastoma in a syngeneic mouse model and induces protective anti-tumor immunity in vivo
    Strassheimer, Florian
    Strecker, Maja
    Alekseeva, Tijna
    Macas, Jadranka
    Demes, Melanie
    Mildenberger, Iris
    Tonn, Torsten
    Wild, Peter
    Sevenich, Lisa
    Reiss, Yvonne
    Harter, Patrick
    Plate, Karlheinz
    Wels, Winfried
    Steinbach, Joachim
    Burger, Michael
    EUROPEAN JOURNAL OF IMMUNOLOGY, 2021, 51 : 115 - 115
12345